Breakthrough trauma pilot clears 60pc of veterans from secondary care

For a veteran who has spent almost 11 years waking from nightmares, a single uninterrupted night's sleep can feel like an achievement beyond reach. Yet that was what one participant experienced during an intensive therapy programme run by Humber Teaching NHS Foundation Trust. The pilot's results are striking: six in ten veterans who took part were able to leave secondary mental health services without needing further treatment.

The programme, delivered through the trust's Traumatic Stress Service, was designed for military veterans living with complex post-traumatic stress disorder (CPTSD). It uses eye movement desensitisation and reprocessing (EMDR), an established psychological treatment for trauma. The trust describes the intensive model as the equivalent of eight months of therapy compressed into a fortnight, offering a different route for veterans struggling with trauma, anxiety and PTSD.

The pilot involved ten veterans, who attended several treatment sessions each day over two weeks. Each day included two individual EMDR sessions, lasting 90 minutes apiece. The remaining timetable combined psychoeducation with group physical activity. Dr Anne Parry and Dr Lynsey Holmes led the programme, supported by a multidisciplinary team of psychologists and an occupational therapist, with a Veterans' Mental Health Practitioner also involved.

The figures reported immediately after the intensive treatment are encouraging. Eight of the ten participants, or 80 per cent, no longer met the diagnostic criteria for CPTSD when the programme ended. Nine in ten required no further treatment for the traumatic memories that had originally brought them to the service. Six participants, representing 60 per cent of the group, needed no further treatment of any kind and were discharged from secondary mental health services.

The distinction matters. Falling below the diagnostic threshold does not necessarily mean that every difficulty has disappeared, while needing no further treatment for the original traumatic memories does not rule out other mental health needs. Four participants required a small number of additional sessions, either to work through another traumatic memory or to address unrelated problems that emerged during therapy. The intensive programme therefore did not bring every case to a close, although the additional treatment required was limited.

For one participant, the change was deeply personal. They described the treatment as difficult but hugely beneficial, saying the team had made them feel safe throughout. Most strikingly, they reported sleeping through the night without a nightmare for the first time in almost 11 years. Trauma-related nightmares are among the familiar and persistent features of PTSD. Research estimates that frequent nightmares affect between 50 and 70 per cent of people with the condition, making their disappearance a particularly meaningful improvement for those who have endured them for years.

The trust believes the programme could have wider implications for the organisation of specialist mental health care. Conventional EMDR pathways can extend over many months and, in some cases, years. By concentrating treatment into a shorter period, the intensive approach could help services respond more quickly to veterans while making better use of clinical appointments. If the results can be sustained and reproduced, shorter episodes of care may also allow clinicians to see other patients sooner, easing some of the pressure on waiting lists.

That possibility comes with considerable demands on participants. Working through distressing memories for extended periods on consecutive days is difficult, and the concentrated format requires a level of commitment that weekly appointments spread over several months may not demand in the same way. A trust spokesperson said feedback from participants had been overwhelmingly positive, with the team placing particular emphasis on making veterans feel supported and safe throughout the process.

There is, however, an important qualification to the results. This remains a pilot involving only ten people, and the figures were recorded immediately after the intensive phase. The trust has not presented them as conclusive evidence that the model will work equally well for a wider population of veterans. An evaluation is continuing to establish whether the improvements are maintained over time. That longer follow-up will be particularly important in determining whether those discharged after treatment remain well and whether the additional support required by some participants can be anticipated in a larger programme.

For commissioners and clinicians, the early findings offer a reason to examine whether the conventional timetable for trauma treatment needs reconsideration. Eight out of ten participants moved below the diagnostic threshold for CPTSD, while six were able to leave secondary mental health care altogether. Those are significant early results, even allowing for the small sample.

If longer-term evaluation confirms that the gains endure, Humber's two-week programme could offer the NHS a more concentrated way of treating veterans whose lives have been shaped by complex trauma. The challenge now is to establish whether the promise seen in ten cases can translate into lasting improvements for many more.